Ketamine Therapy vs. Benzos: A Better Path for Anxiety?

Side-by-Side Comparison Table

The following table outlines the primary differences between at-home ketamine therapy and traditional benzodiazepines.

*Note: Mindbloom's real-world adverse-event-driven discontinuation rate was 0.4%, while the benzodiazepine meta-analysis reported an all-cause discontinuation odds ratio of 1.43 versus placebo across 15 randomized controlled trials. The contrast is directional rather than an apples-to-apples comparison due to differences in study designs and populations.

What Are Benzodiazepines Like Xanax and Klonopin?

Benzodiazepines are a class of medications that enhance the effect of the neurotransmitter GABA at the GABA-A receptor to produce anxiolytic, sedative, and muscle-relaxant effects. The four most commonly prescribed benzodiazepines for anxiety include:

• Alprazolam: Sold under the brand name Xanax.
• Clonazepam: Sold under the brand name Klonopin.
• Lorazepam: Sold under the brand name Ativan.
• Diazepam: Sold under the brand name Valium.

In the a leading pharmacotherapy review (Strawn 2018), benzodiazepines are classified as a second-line pharmacotherapy for adult generalized anxiety disorder (GAD), behind SSRIs and SNRIs as first-line.¹ Expert consensus reinforces this position.² Despite the second-line classification, their rapid onset of 30 to 60 minutes makes them appealing for acute anxiety episodes.

A 2007 effect-size analysis of pharmacologic treatments for generalized anxiety disorder (Hidalgo et al., Journal of Psychopharmacology) found that the measured advantage of benzodiazepines over a placebo sugar pill is roughly the same as the measured advantage of SSRIs over a placebo sugar pill. Across the published GAD pharmacotherapy literature, benzodiazepines are not categorically more effective than other first-line anxiety medications when compared against placebo.⁷

Among the four most commonly prescribed benzodiazepines for anxiety, only alprazolam (Xanax) is FDA-approved for GAD. Clonazepam, lorazepam, and diazepam are prescribed off-label.¹ Off-label prescribing is a normal feature of psychiatry, and many anxiety treatments, including ketamine therapy, are prescribed off-label by licensed clinicians based on clinical judgment and published research.

In other words: benzodiazepines are not first-line for anxiety, the degree to which they outperform first-line alternatives is in question, and only one of the four most-prescribed compounds is FDA-approved for the treatment. The case for or against them lives in how they are tolerated and how they are structured, not in their measured effectiveness.

What Is Ketamine Therapy for Anxiety?

Ketamine is an NMDA receptor antagonist with hypothesized effects on glutamate signaling and neural connectivity. The FDA approved it as an anesthetic in 1970, and it has been on the WHO List of Essential Medicines since 1985.³ Like most benzodiazepines prescribed for anxiety, ketamine is used off-label for the treatment of anxiety, depression, and PTSD. Off-label prescribing is a normal feature of psychiatry, supported in ketamine's case by a substantial body of peer-reviewed research and decades of FDA-approved use as an anesthetic.

Unlike daily medications, ketamine therapy is session-based and course-driven. The therapeutic model involves preparation, a supervised session, and guided integration practices. Mindbloom has published peer-reviewed, real-world effectiveness data on its own protocol, including a cohort of 11,441 clients.⁴

Noticeable symptom improvement can occur within hours or days of the first session, with more durable benefits developing over a series of sessions.⁸ Decades of anesthetic use and a growing body of peer-reviewed research support ketamine's role in mental health treatment.⁹

How Does Ketamine Work Differently From Benzodiazepines?

These two medications target fundamentally different receptor systems and follow different care models. Benzodiazepines modulate GABA-A receptors, while ketamine acts on NMDA receptors.

• Benzodiazepines: GABA-A allosteric modulators that enhance inhibitory signaling.1 They provide anxiolysis within 30 to 60 minutes per dose, with the effect fading over hours. The mechanism temporarily dampens the experience of anxiety as it occurs, which is why they are typically prescribed for daily or as-needed use.Ketamine therapy:NMDA receptor antagonism which research suggests triggers downstream changes in glutamate signaling and synaptic plasticity. The session-based experience is designed to create psychological space, allow for insights, and support a different relationship with the thoughts and patterns that drive anxiety. The protocol is structured around a defined course rather than ongoing daily use.

Put plainly: benzodiazepines temporarily quiet the experience of anxiety as it happens. Ketamine therapy is structured to change a patient's underlying relationship with anxiety across a course of treatment. The two serve different therapeutic goals

Is Ketamine Therapy Better Tolerated Than a Benzodiazepine?

How well patients tolerate a treatment, whether side effects are acceptable enough to continue care, is a core measure in medical research. Researchers typically measure it by looking at discontinuation rates.

A large network meta-analysis found that paroxetine and benzodiazepines were effective but also poorly tolerated when compared with placebo.⁵ The all-cause discontinuation odds ratio versus placebo was 1.43 across 15 trials totaling 1,019 patients.⁵ For comparison within that same analysis, medications like escitalopram and sertraline were better tolerated than benzodiazepines.

Mindbloom's ketamine therapy shows a different tolerability profile. In Mindbloom's published study of 11,441 patients, the adverse-event-driven discontinuation rate was 0.4%.⁴ An earlier Mindbloom study of 1,247 patients showed a 0.5% discontinuation rate.⁶ Side effects occur in approximately 4 to 5% of sessions, and serious adverse events occur in fewer than 0.1% of sessions.^4,6

Discontinuation rates are only one piece of the tolerability picture. Because benzodiazepines are taken throughout the day to manage anxiety as it occurs, documented side effects like falls, hip fractures, and cognitive impairment can carry into work, driving, and other daily activities.¹⁰ Ketamine therapy contains its acute effects to a dedicated session window, with monitoring during the session and instructions not to drive or operate machinery until the following day.

Do You Take Ketamine Every Day Like Xanax or Klonopin?

No. The vast majority of therapeutic ketamine for anxiety is delivered at a structured cadence rather than as a daily pill. A small number of providers market daily low-dose oral ketamine, but the research base supporting that protocol is limited and the practice is not widely adopted in clinical ketamine therapy. Mindbloom delivers ketamine as a defined session-based course, not a daily medication.

By contrast, benzodiazepines are typically prescribed for daily or as-needed use. Current prescribing guidelines describe benzodiazepine therapy for adults as appropriate for short-term use of three to six months.¹

The same review notes that this time frame falls short of addressing the chronic nature of GAD¹. Guidelines therefore face a prescribing dilemma: they recommend short-term use for a chronic condition. Generalized anxiety disorder is widely described in the clinical literature as persisting for years rather than resolving over weeks or months, meaning the underlying anxiety often remains well after the recommended benzodiazepine prescribing window has closed. A short-term prescription can help manage acute symptoms during that window, but it is not designed to address the underlying condition over the course it typically follows.

In other words: a benzodiazepine prescription may help manage acute symptoms for a few months, but anxiety itself usually does not resolve on that timeline. Whatever was driving the anxiety is likely still present when the prescription ends.

Does Ketamine Therapy Actually Work for Anxiety?

Yes. Peer-reviewed research indicates ketamine therapy can be highly effective for anxiety. Anxiety treatment effectiveness is measured with the Generalized Anxiety Disorder 7-item scale (GAD-7), a validated questionnaire used across clinical research. Mindbloom has published peer-reviewed outcomes data on its own protocol in the Journal of Affective Disorders.⁴

In Mindbloom's published data of more than 7,700 anxiety patients, 56% achieved at least a 50% reduction in GAD-7 anxiety scores after approximately 4 weeks of at-home ketamine therapy treatment (response rate). 28.8% of patients reached remission, meaning their GAD-7 score dropped below 5 (Mathai 2024). The baseline GAD-7 average across the cohort dropped from 15.2 to 7.6, and the symptom deterioration rate was 0.4%.

In Hull 2022, an earlier peer-reviewed Mindbloom study, the 937 anxiety patients within the broader 1,247-patient cohort showed similar response and remission rates.⁷ Individual results may vary.

For context on evidence-base scale, Mindbloom's GAD-7 cohort is approximately seven and a half times the largest GAD network meta-analysis published to date (Slee et al. 2019, The Lancet).⁵

Can Mindbloom Be Combined With Other Anxiety Treatments?

Yes, in most cases. Many people continue their existing therapy, medication management, and other provider-directed supports while undergoing ketamine therapy, and most psychiatric medications can be safely maintained throughout a course of treatment.

Mindbloom is delivered alongside your existing care team. Any taper, transition, or medication adjustment is managed in collaboration with your prescribing physician, and the program's preparation, in-session support, and integration practices can reinforce skills developed in therapy or other modalities. In some cases, your clinician may suggest adjustments to your existing medication schedule to ensure that medications interact safely with ketamine. Sharing your full medication list with both your Mindbloom provider and prescribing physician helps ensure care is coordinated.

Which Option Is Right for Your Anxiety Treatment Goals?

Choosing between these options requires assessing which care model aligns with your needs, preferences, and circumstances.

A benzodiazepine may align with your needs if:

• You need rapid, per-dose relief for acute anxiety episodes.
• Your physician has recommended short-term pharmacotherapy as part of a broader care plan.
• You are looking for an as-needed option alongside other first-line treatments.

Ketamine therapy may align with your needs if:

• You are looking for a time-limited treatment course rather than daily medication.
• You want a session-based approach with preparation, medical oversight, and integration support.
• You prefer carving out dedicated session time for treatment rather than carrying medication effects through your daily life.
• You are approaching or past the short-term prescribing window described in current benzodiazepine guidelines.

For patients reaching the short-term prescribing window described in current benzodiazepine guidelines, Mindbloom's defined program and published outcomes across more than 11,000 patients make it a reasonable option to discuss with a provider.

Important Safety Information

Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment. Individual results may vary. Full safety information: www.mindbloom.com/safety-information

Off-Label Use Disclosure

Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.